Recent findings in the regulation of G6PD and its role in diseases
- PMID: 36091812
- PMCID: PMC9448902
- DOI: 10.3389/fphar.2022.932154
Recent findings in the regulation of G6PD and its role in diseases
Abstract
Glucose-6-phosphate dehydrogenase (G6PD) is the only rate-limiting enzyme in the pentose phosphate pathway (PPP). Rapidly proliferating cells require metabolites from PPP to synthesize ribonucleotides and maintain intracellular redox homeostasis. G6PD expression can be abnormally elevated in a variety of cancers. In addition, G6PD may act as a regulator of viral replication and vascular smooth muscle function. Therefore, G6PD-mediated activation of PPP may promote tumor and non-neoplastic disease progression. Recently, studies have identified post-translational modifications (PTMs) as an important mechanism for regulating G6PD function. Here, we provide a comprehensive review of various PTMs (e.g., phosphorylation, acetylation, glycosylation, ubiquitination, and glutarylation), which are identified in the regulation of G6PD structure, expression and enzymatic activity. In addition, we review signaling pathways that regulate G6PD and evaluate the role of oncogenic signals that lead to the reprogramming of PPP in tumor and non-neoplastic diseases as well as summarize the inhibitors that target G6PD.
Keywords: glucose-6-phosphate dehydrogenase; metabolic reprogramming; pentose phosphate pathway; post-translational modifications; tumorigenesis.
Copyright © 2022 Meng, Zhang, Hao, Sun, Liu, Zhou, Wang and Xu.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures



Similar articles
-
The Emerging Roles of the Metabolic Regulator G6PD in Human Cancers.Int J Mol Sci. 2023 Dec 7;24(24):17238. doi: 10.3390/ijms242417238. Int J Mol Sci. 2023. PMID: 38139067 Free PMC article. Review.
-
PBX3 promotes pentose phosphate pathway and colorectal cancer progression by enhancing G6PD expression.Int J Biol Sci. 2023 Aug 28;19(14):4525-4538. doi: 10.7150/ijbs.86279. eCollection 2023. Int J Biol Sci. 2023. PMID: 37781025 Free PMC article.
-
TRAF6-Mediated SM22α K21 Ubiquitination Promotes G6PD Activation and NADPH Production, Contributing to GSH Homeostasis and VSMC Survival In Vitro and In Vivo.Circ Res. 2015 Sep 25;117(8):684-94. doi: 10.1161/CIRCRESAHA.115.306233. Epub 2015 Aug 19. Circ Res. 2015. PMID: 26291555
-
KLF8 Promotes the Survival of Lung Adenocarcinoma During Nutrient Deprivation by Regulating the Pentose Phosphate Pathway through SIRT2.Front Biosci (Landmark Ed). 2024 Jan 18;29(1):27. doi: 10.31083/j.fbl2901027. Front Biosci (Landmark Ed). 2024. PMID: 38287804
-
Glucose-6-phosphate dehydrogenase: a therapeutic target for ovarian cancer.Expert Opin Ther Targets. 2023 Jul-Dec;27(8):733-743. doi: 10.1080/14728222.2023.2247558. Epub 2023 Aug 18. Expert Opin Ther Targets. 2023. PMID: 37571851 Review.
Cited by
-
Mitochondrial dysfunction and disulfidptosis co-regulate neuronal cell in neuropathic pain based on bioinformatics analysis.Mol Pain. 2024 Jan-Dec;20:17448069241290114. doi: 10.1177/17448069241290114. Mol Pain. 2024. PMID: 39323309 Free PMC article.
-
G6PDi-1 is a Potent Inhibitor of G6PDH and of Pentose Phosphate pathway-dependent Metabolic Processes in Cultured Primary Astrocytes.Neurochem Res. 2023 Oct;48(10):3177-3189. doi: 10.1007/s11064-023-03964-2. Epub 2023 Jul 2. Neurochem Res. 2023. PMID: 37394677 Free PMC article.
-
CD44-mediated metabolic rewiring is a targetable dependency of IDH-mutant leukemia.Blood. 2025 Apr 3;145(14):1553-1567. doi: 10.1182/blood.2024027207. Blood. 2025. PMID: 39841003
-
Construction of an Oxidative Stress Risk Model to Analyze the Correlation Between Liver Cancer and Tumor Immunity.Curr Cancer Drug Targets. 2025;25(1):49-63. doi: 10.2174/0115680096284532231220061048. Curr Cancer Drug Targets. 2025. PMID: 38375834
-
CDK5-triggered G6PD phosphorylation at threonine 91 facilitating redox homeostasis reveals a vulnerability in breast cancer.Acta Pharm Sin B. 2025 Mar;15(3):1608-1625. doi: 10.1016/j.apsb.2024.12.019. Epub 2024 Dec 25. Acta Pharm Sin B. 2025. PMID: 40370560 Free PMC article.
References
-
- Au S. W., Naylor C. E., Gover S., Vandeputte-Rutten L., Scopes D. A., Mason P. J., et al. (1999). Solution of the structure of tetrameric human glucose 6-phosphate dehydrogenase by molecular replacement. Acta Crystallogr. D. Biol. Crystallogr. 55 (4), 826–834. 10.1107/s0907444999000827 - DOI - PubMed
-
- Aurora A. B., Khivansara V., Leach A., Gill J. G., Martin-Sandoval M., Yang C., et al. (2022). Loss of glucose 6-phosphate dehydrogenase function increases oxidative stress and glutaminolysis in metastasizing melanoma cells. Proc. Natl. Acad. Sci. U. S. A. 119 (6), e2120617119. 10.1073/pnas.2120617119 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous